Main navigation
Labels
- 'Nature-inspired' drug development (1)
- (3D) in vitro models (2)
- 3-dioxygenase (1)
- 3-MCA (1)
- 3D (2)
- 3D migration (1)
- 3D printing (1)
- 4C-seq (2)
- A20 (2)
- Abraxane™ (1)
- academic clinical trials (2)
- accelerated radiotherapy (1)
- access to care (1)
- accredited FCM analysis (1)
- aCGH (1)
- AcTaferon (2)
- AcTakine (3)
- actin cytoskeleton (1)
- actionable mutations (1)
- activity-based costing (1)
- Acute Lymphoblastic Leukemia (6)
- Acute myeloid leukemia (6)
- Adhesion (2)
- adipose tissue (1)
- adjuvants (1)
- ALL (1)
- alpha-tubulin (2)
- AML (2)
- analytics (1)
- angiogenesis (5)
- animal models (2)
- anti-metastatic compounds (1)
- antibody recruitment (1)
- antigen (1)
- antisense oligonucleotides (1)
- antisense technology (3)
- apc (1)
- Apoptosis (2)
- assays (2)
- ATAC-sequencing (2)
- ATMP (2)
- AuNP (1)
- automated quantification (1)
- automation (1)
- autophagy (1)
- azoxymethane (1)
- B cell lymphoma (2)
- B16F10 (1)
- BACR (2)
- Bacteria (1)
- BCCM-LMBP (2)
- big data (31)
- Bimetra (2)
- Binding-affinity (1)
- bio-imaging (2)
- bio-informatics (2)
- biobank (5)
- Biobank initiatives (1)
- biodistribution (2)
- biodosimetry (1)
- Biofluids (4)
- bioimmunoengineering (1)
- bioinformatics (36)
- biologics (2)
- bioluminescence (2)
- biomarker (14)
- Biomarker discovery (1)
- biomarker identification (2)
- biomaterials (1)
- biomedical engineering (1)
- biomimetics (1)
- biomolecular interactions (1)
- biopharmaceuticals (3)
- bioprinting (2)
- biotransport (1)
- bladder cancer (4)
- blebbistatin (1)
- Blood tests (1)
- blood-based biomarkers (3)
- body-fluids (1)
- bone tumor (2)
- brain cancer (9)
- breast cancer (34)
- Breast Cancer Tumorigenesis (1)
- breathomics (1)
- BSPHO (2)
- business development (2)
- Busulfan (1)
- CA4P (1)
- cadherins (2)
- caecum (1)
- CAF (1)
- CAM (1)
- cancer cell biology (39)
- cancer cell development (21)
- cancer cell trap (1)
- cancer cell-specific EVs (1)
- cancer immunotherapy (3)
- cancer invasion (1)
- cancer metabolism (1)
- Cancer models (1)
- cancer predisposition (3)
- cancer stem cells (21)
- cancer therapy (3)
- cancer type specificity (2)
- cancer vaccination (3)
- cancer-associated fibroblasts (3)
- cancerogenesis (1)
- canine model (1)
- capillary electrophoresis (1)
- capsules (1)
- CAR T cells (1)
- Carcinoma (1)
- carcinomatosis (2)
- care (24)
- cat (1)
- cell death (6)
- cell death mechanisms (6)
- cell invasion (1)
- Cell line (2)
- cell migration (2)
- cell printing (1)
- cell sorting (1)
- Cell therapy (2)
- cell-based (3)
- CellMissy (1)
- Cellular bioenergetics (1)
- central point of contact (1)
- cervical cancer (18)
- cfDNA (1)
- checkpoint inhibitors (2)
- chemistry tools (1)
- chemoembolization (1)
- chemoresistance (1)
- ChemTech (1)
- chimeric antigen receptor (1)
- ChIP-seq (3)
- chromium (1)
- chronic myeloid leukemia (1)
- chrystallography (1)
- circulating RNA biomarkers (1)
- circulating tumor cells (2)
- circulating tumor markers (1)
- cirrhosis (1)
- CISH (1)
- Cisplatin (1)
- clinical cancer research (34)
- Clinical research (2)
- Clinical trial (39)
- clinical trial center (1)
- CLL (2)
- coating (1)
- Coding (1)
- cohort analysis (1)
- colon cancer (29)
- colorectal (29)
- colorectal carcinogenesis (3)
- Commissie Oncology (1)
- Commission Oncology (1)
- compounds (1)
- computational fluid dynamics (3)
- computed tomography (1)
- computer modelling (1)
- continuous flow (2)
- contrast imaging (1)
- controlled drug release (2)
- Controlled release (1)
- coordinator (1)
- copy number data (1)
- crawl position (1)
- CRISPR-Cas (9)
- CRISPR/Cas9 (1)
- crosslink (1)
- crystal digital PCR (1)
- Crystal Miner software (1)
- crystallography (1)
- CT (2)
- CTCs (1)
- Culture collection (1)
- cutaneous melanoma (1)
- Cytokine (4)
- cytokine therapy (3)
- cytokines (3)
- cytotoxicity (2)
- DAMPs (1)
- data integration (5)
- Data Management (2)
- Data Mining (3)
- de novo lipogenesis (1)
- decision-analytic models (1)
- degranulation (1)
- dendritic cell (3)
- dendritic cell therapy (3)
- density gradient (1)
- Dermoscopy (1)
- Desmoid tumor (2)
- desmoid tumors (3)
- detection (67)
- development planning (1)
- diagnosis (67)
- diagnostics (8)
- dicentric assay (1)
- dietary carcinogens (4)
- differentiation (3)
- diffuse large B cell lymphoma (1)
- digestion metabolites (1)
- digital PCR (1)
- diketopiperazines (2)
- dispersity (1)
- DLS (1)
- DNA adductomics (3)
- DNA fragmentation (2)
- DNA repair (3)
- DNA repair mechanism (1)
- DNA sequencing (1)
- dog (1)
- dogs (1)
- donations (1)
- dorsal skinfold chamber (1)
- dPCR (2)
- driver identification (1)
- Drug conjugation (1)
- drug delivery (45)
- drug discovery (45)
- Drug distribution (1)
- drug repurposing (2)
- drug response (1)
- drug screening (5)
- drug targets (1)
- drug testing (1)
- Drug Transport (1)
- DSA-FACE (1)
- Ductal carcinoma in situ (1)
- dynamic network (1)
- early detection (1)
- early phase clinical trials (2)
- economics (1)
- Electron microscopy (4)
- electroporation (1)
- elemental imaging (1)
- embryonic stem cells (4)
- EMT (10)
- endosomal escape (3)
- enhancers (1)
- environmental pollutants (1)
- enzyme inhibitors (1)
- epidemiology (3)
- epigenetics (9)
- Epigenomics (7)
- Epithelial mesenchymal transition (2)
- Epithelial ovarian cancer (1)
- ER Stress (3)
- esophageal adenocarcinoma (1)
- etiology (13)
- evidence-based needs assessment (1)
- ex-vivo (1)
- ex-vivo imaging (1)
- exercise science (1)
- exosomal RNA (1)
- Exosomes (6)
- expression screen (1)
- Extracellular matrix (3)
- extracellular RNA (2)
- Extracellular Vesicles (13)
- Eye cancer (1)
- FFPE samples (1)
- fibrosis (1)
- FISH (4)
- Flow cytometry (7)
- fluorescence (1)
- Fluorescence-in-situ hybridization (2)
- fluorophore (1)
- foci (1)
- Food - drug interaction (1)
- Formulation (2)
- fragment-based X-ray screening (1)
- functional assays (1)
- gastric cancer model (1)
- Gastro-intestinal (1)
- GCP (1)
- gene editing (3)
- gene perturbation (1)
- gene therapy (3)
- gene/protein expression (1)
- genetic predisposition (2)
- genome editing (3)
- genome engineering (2)
- genome-wide (1)
- Genomics (5)
- genotoxicity (1)
- germline and somatic mutation detection (1)
- glioblastoma (6)
- glioma (4)
- Glucocorticoid receptor (2)
- Glucocorticoid resistance (2)
- Glucocorticoids (3)
- glycan (1)
- glycan analytics (1)
- glyco-engineering (1)
- glycolipid antigens (1)
- Glycomics (3)
- glycosylation (2)
- GMP (3)
- gnotobiotic mice (1)
- GPC (1)
- grants (12)
- granzyme (1)
- growth factor (1)
- gut (1)
- gynaecological cancer (1)
- haematopoiesis (1)
- HDAC inhibitors (1)
- HDAC6 (2)
- head cancer (13)
- healt economics (1)
- health technology assessment (1)
- Healthy Volunteers (1)
- Hedgehog signaling (1)
- hematology (1)
- hematopoiesis (1)
- hematopoietic stem cell (1)
- Hematopoietic stem cells (3)
- Hepatocellular cancer (1)
- hepatocellular carcinogenesis (3)
- hepatocellular carcinoma (9)
- hepatopulmonary syndrome (1)
- hereditary cancer (1)
- heterocycles (1)
- HIFU (1)
- high intensity focused ultrasound (1)
- high performance computing (2)
- High resolution mass spectrometry (5)
- high-content screening (4)
- high-throughput screening (3)
- HIPEC (1)
- histochemistry (1)
- Histopathology (3)
- homologous recombination (2)
- Host-microbe interactions (5)
- human liver samples (1)
- Humanized immune system mice (1)
- Humanized mice (1)
- Hybridoma (1)
- hydrogels (3)
- hyperthermia (1)
- hypofractionation (2)
- hypoxia (2)
- ICP-mass spectrometry (2)
- imaging (6)
- imaging-guided surgery (1)
- immune cell development (1)
- immune recovery (1)
- immune related adverse events (1)
- Immune response (1)
- immuno-oncology (5)
- Immunoassays (1)
- immunochemotherapy (1)
- Immunoconjugates (1)
- Immunocytokine (1)
- Immunodeficient mice (1)
- immunogenic cell death (5)
- immunogenicity (1)
- Immunohistochemistry (4)
- immunology (45)
- immunometabolism (1)
- immunomics (1)
- immunomodulators (1)
- immunophenotyping (1)
- immunosuppression (1)
- immunotherapy (53)
- imprinting (1)
- in vitro assay (1)
- in vitro model (2)
- in vitro T cell generation (1)
- in vivo imaging (8)
- in vivo microscopy (1)
- in vivo model (7)
- in vivo optical imaging (4)
- induced pluripotent stem cells (3)
- infectious diseases (1)
- inflammation (7)
- inhibitory receptor (1)
- iNKT cells (1)
- iNKT ligands (1)
- innate immune system (1)
- innovation (2)
- intact protein mass spec (1)
- integrative genomics (1)
- intellectual property (3)
- interactions (1)
- Interactomics (2)
- Interferon (1)
- Interferons (1)
- intracellular delivery (4)
- Intraperitoneal Chemotherapy (3)
- intraperitoneal drug delivery (3)
- intravital microscopy (1)
- Invasion (4)
- Invasion analysis (1)
- irAE's (1)
- isotope ratio (2)
- isotopic composition (1)
- IVM (1)
- juvenile myelomonocytic leukemia (3)
- kidney cancer (6)
- kinetic imaging (1)
- Kinetics (1)
- Kom op tegen Kanker (1)
- Koninklijke Academie Geneeskunde (1)
- kydney cancer (1)
- laparoscopy (1)
- laparotomy (1)
- large animal (1)
- laser capture microdissection (3)
- LC-MS (2)
- LCM (1)
- leukemia (33)
- leukemic stem cell (2)
- licensing (2)
- light scattering (1)
- Lipidomics (3)
- liposomes (3)
- liquid biopsies (8)
- liquid biopsy (10)
- liquid chromatography mass spectrometry (1)
- live cell (1)
- live-cell imaging (2)
- liver cancer (15)
- lncRNA (3)
- logo (1)
- long non-coding RNA (9)
- luminescence (2)
- Luminex (1)
- Lung cancer (11)
- lung cancer model (1)
- lung surfactant (1)
- lymph node irradiation (1)
- Lymphoma (9)
- lysosomes (1)
- machine learning (2)
- macrophages (1)
- MALT1 (1)
- mamalian protein expression (1)
- mammary fat pad (1)
- mammography (2)
- mass spectrometry (6)
- mast cell tumor (2)
- mastocytosis (2)
- MDG (2)
- MDSC (1)
- mechanistic biology (1)
- medical devices (1)
- Medicinal chemistry (2)
- Melanocyte (3)
- Melanoma (24)
- mesothelial-mesenchymal transition (1)
- mesothelioma (3)
- metabolism (2)
- Metabolomics (5)
- Metastasis (8)
- Metastasis and the tumor microenvironment (1)
- metastasis-directed therapy (1)
- microbial metabolites (1)
- microbiome (4)
- Microbiota (3)
- microbubbles (5)
- Microfluidic chip (1)
- micronucleus (1)
- micronucleus assay (1)
- micropeptides (1)
- microreactor (2)
- microRNA (7)
- microscopy (3)
- microspheres (1)
- migration parameters (1)
- Mineralocorticoid receptor (1)
- MMT (1)
- MOC (2)
- mode of action (1)
- modelling and simulation (1)
- models of metastasis (1)
- molecular cloning (1)
- molecular diagnostics (1)
- molecular signaling (1)
- mouse models (9)
- MPS (1)
- MRD (2)
- MRI (7)
- mRNA (2)
- mRNA therapeutics (3)
- mRNA vaccination (2)
- mRNA vaccines (1)
- Mucositis (1)
- multi-omics analysis (2)
- Multiple myeloma (5)
- Multiplex (1)
- mycotoxins (4)
- myelodysplasia (1)
- myeloid-derived suppressor cells (1)
- N-glycan (2)
- Naica System (1)
- nanodelivery (1)
- nanomedicine (2)
- Nanoparticle Tracking Analysis (5)
- nanoparticles (17)
- nanotechnology (38)
- National study coordinator (1)
- natural killer (1)
- natural products (2)
- neck cancer (13)
- necroptosis (2)
- necrosis (1)
- neoantigens (1)
- NESPR (1)
- network analysis (2)
- network inference (1)
- network modelling (1)
- networks (3)
- neuroblastoma (39)
- new chemical entities (1)
- next generation sequencing (8)
- NF-kB (3)
- NK cell (1)
- NKT cells (1)
- NOD/scid/gamma mouse (1)
- Non-alcoholic fatty liver disease (1)
- non-coding mutations (1)
- non-coding RNA (10)
- non-viral gene therapy (3)
- NRF2 (1)
- NSG (1)
- NSG in vivo model (4)
- nuclear medicine (1)
- nucleic acid (1)
- nucleoside analogues (1)
- nutrigenomics (1)
- Oligometastases (2)
- omics (56)
- omics data (2)
- oncogenic receptors (1)
- Oncological center (2)
- Oncologisch Centrum (3)
- Oncolunch (4)
- OncoPoint (1)
- ORFeome (1)
- Organic chemistry (2)
- organoids (1)
- organomimetics (1)
- out-licensing (2)
- outcomes research (1)
- Ovarian cancer (21)
- pan-cancer (19)
- pancreatic cancer (4)
- PARP inhibitor (2)
- particles (1)
- partnering issues (1)
- patent (1)
- patent management (1)
- pathway activity scores (1)
- patient experience (25)
- patient reported outcomes (2)
- patient subtyping (1)
- patient treatment (24)
- patient-derived xenografts (3)
- patient-specific (1)
- PBMC (1)
- pDNA (1)
- PDX (4)
- pediatric acute myeloid leukemia (1)
- pediatric cancer (6)
- pediatric clinical trials (1)
- Pediatric Coordination Cell (1)
- pediatric leukemia (1)
- Peptide nucleic acids (1)
- perforin (1)
- peritoneal carcinomatosis (11)
- peritoneal metastasis (4)
- peritoneum (6)
- Personalized cancer therapy (3)
- personalized medicine (2)
- PET (8)
- pharmacogenomics (1)
- pharmacokinetics (2)
- Phase I (2)
- Phenotype-switching (3)
- phenotypic (2)
- phoshorus (1)
- phosphorus (1)
- photodynamic therapy (1)
- photoporation (1)
- Pichia pastoris (2)
- Pig (1)
- PIPAC (3)
- plasma biomarker (2)
- plasma proteins (1)
- plasma RNA sequencing (2)
- platinum resistant ovarium cancer (1)
- PNA (1)
- polymer therapeutic (3)
- polymers (7)
- Polyphenol (1)
- population screening (1)
- portal hypertension (1)
- portfolio building (1)
- portopulmonary hypertension (1)
- positional proteomics (1)
- posttranslational modifications (1)
- Precision medicine (5)
- preclinical animal models (5)
- predictive models (1)
- pressurized intraperitoneal aerosol chemotherapy (1)
- primary hepatocytes (1)
- Primary xenografts (1)
- prognosis (70)
- prone crawl position (1)
- prone position (1)
- prone radiotherapy (2)
- Prostate cancer (20)
- prostatectomy (1)
- protein chemistry (2)
- protein complexes (4)
- protein identification (2)
- protein modification (1)
- protein purification (2)
- protein quantification (1)
- protein seperation (1)
- protein technology (1)
- Protein-protein interaction (1)
- Proteoglycans (1)
- proteomics (8)
- psychology (2)
- psychosociaal oncologisch team (2)
- psychosocial research (2)
- public health (1)
- Publications (1)
- qPCR (2)
- quality assurance (1)
- quality of life (4)
- quantification (1)
- quantitative metabolite profiling (1)
- R&D partnering (1)
- rabbit (1)
- radiation exposure (2)
- radiation necrosis (1)
- radiation-induced DNA damage (1)
- radioembolization (1)
- radiogenomics (1)
- radiopharmacy (1)
- radiosensitivity (2)
- radiotherapy (16)
- rare cell isolation (2)
- Rational drug design and QSAR modeling (1)
- real-time imaging (1)
- Receptor (1)
- receptor tyrosine kinase (1)
- receptors (1)
- recombinant protein (2)
- red meat (1)
- Regenerative and neoplastic inflammation (1)
- regulatory network inference (1)
- regulatory T cells (1)
- rehabilitation (2)
- replicative stress (3)
- research & innovation management (1)
- retinoblastoma (2)
- Reverse Genetics (1)
- ribo-seq (1)
- RNA quality (1)
- RNA sequencing (7)
- RNA-protein interactions (1)
- sample disruption (1)
- sample preparation (1)
- Sapphire chip (1)
- Sarcoma (6)
- sarcomagenesis (1)
- SBRT (3)
- scaffolds (2)
- science communication (1)
- SEC (1)
- Selective glucocorticoid receptor modulator (1)
- Selective glucocorticoid receptor modulator SEGRM (1)
- Self Amplifying mRNA (1)
- sequencing (4)
- shallow whole genome sequencing (1)
- sheep (1)
- shRNA (1)
- Signal transduction (35)
- signaling (35)
- single cancer cell (1)
- single cell (7)
- single cell analysis (6)
- Single cell transcriptomics (6)
- Single Particle Tracking (1)
- siRNA (7)
- siRNA screening (1)
- size and density based separation (1)
- size-based chromatography (1)
- sizing (1)
- Skin cancer (23)
- skin cancer model (1)
- Skin cancer prevention (22)
- slug (1)
- small animal imaging (7)
- Small molecules (1)
- small-molecule drugs (1)
- snai1 (1)
- SPECT (2)
- spectroscopy (2)
- spontaneous cancer (2)
- SQSTM1 (1)
- statistics (2)
- Stem cell angiogenesis (1)
- stem cell transplantation (1)
- stem cells (3)
- structural biology (2)
- subcellular (1)
- subtyping (1)
- supportive care (1)
- synthesis (2)
- synthetic biology (1)
- synthetic methodology (2)
- synthetic mRNA (1)
- T cell differentiation (1)
- T cell immunotherapy (1)
- T cell receptor (2)
- T cell therapy (3)
- T cells (3)
- T lymphocyte (2)
- T-ALL (9)
- T-cell acute lymphoblastic leukemia (5)
- TALEN (1)
- targeted drug delivery (1)
- Targeted therapy (3)
- TCR transgenic T cells (1)
- technology & business development (2)
- technology development (38)
- technology transfer (1)
- telomere biology (1)
- testicular cancer (4)
- the cancer genome atlas (2)
- theranostics (3)
- therapeutic enzymes (1)
- therapeutic monitoring (1)
- Therapeutic target identification (1)
- therapy resistance (2)
- therapy response (2)
- therapy response prediction (2)
- thymus (1)
- thyroid cancer (6)
- time lapse microscopy (1)
- tissue engineering (1)
- Tissue Lyser (1)
- tissue printing (2)
- tissue spheroids (1)
- trace elements (3)
- tracking (1)
- trajectory inference (1)
- transarterial therapy (1)
- Transcriptional Regulation (4)
- transcriptomics (18)
- transcriptomics (1)
- transgenerational (1)
- Transgenic Mouse models (2)
- Translational Oncology Unit (7)
- Triple negative breast cancer (1)
- tumor biobank (1)
- tumor biomimics (1)
- tumor cell vaccine (1)
- tumor ecosystem (1)
- Tumor heterogeneity (2)
- Tumor hypoxia (1)
- Tumor immunology (5)
- Tumor immunology and immunotherapy (44)
- Tumor initiation and progression (1)
- tumor load (1)
- Tumor metabolism (1)
- Tumor microenvironment (37)
- tumor penetration (1)
- tumor spheroid (1)
- tumor targeted delivery (1)
- tumor-infiltrating lymphocytes (1)
- tumour prophylactic vaccination model (1)
- twist (1)
- ubiquitination (1)
- ultrasound (6)
- ultrasound contrast agents (1)
- unfolded protein response (1)
- UPR (1)
- urinalysis (1)
- urinary biomarkers (3)
- urokinase plasminogen activator (1)
- uterine cancer (1)
- UV/Vis absorbance (1)
- vaccination (1)
- vaccine (3)
- vaginal cancer (1)
- vascular disruptive agent (1)
- vesicle trafficking (1)
- virus-like particles (1)
- volatile organic compounds (1)
- vulvar cancer (1)
- WES (1)
- WGS (2)
- whole-breast irradiation (1)
- Wnt signaling (1)
- xenograft (6)
- xenograft and orthotopic carcinogen-induced models (1)
- Xenopus (4)
- Xenopus tropicalis (4)
- yeast (2)
- ZEB1 (5)
- ZEB1/2 (2)
- Zeb2 (4)
- zebrafish (11)